2490 Ribosomal protein L13/L15p/L18e/L32e
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 73 | 39.7 | 1.84× | q < 0.0001 | |
| Organic acids and derivatives | 3 | 12.5 | 0.24× | q = 4.0e-3 | |
| Homogeneous non-metal compounds | 4 | 17.4 | 0.23× | q = 2.0e-4 | |
| Organic oxygen compounds | 2 | 16.1 | 0.12× | q < 0.0001 | |
| Organoheterocyclic compounds | 1 | 12.4 | 0.08× | q = 1.2e-4 | |
| Nucleosides, nucleotides, and analogues | 1 | 22.4 | 0.04× | q < 0.0001 | |
| Benzenoids | 0 | 5.9 | 0 | q = 8.8e-3 | |
| Lipids and lipid-like molecules | 0 | 9.0 | 0 | q = 3.8e-4 | |
| Organic nitrogen compounds | 15 | 2.6 | 5.82× | not tested | |
| Mixed metal/non-metal compounds | 5 | 1.7 | 2.94× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03566 | SPD | Spermidine | 28 |
| DB00161 | VAL | Valine | 6 |
| DB01917 | PUT | Putrescine | 6 |
| DB00120 | PHE | Phenylalanine | 2 |
| DB01421 | PAR | Paromomycin | 1 |
| DB02494 | — | (S)-3-phenyllactic acid | 1 |
| DB03685 | U | Uridine monophosphate | 1 |
| DB04729 | LLL | Gentamicin C1a | 1 |
| DB05636 | YMZ | (+)-Mefloquine | 1 |
| DB07374 | — | — | 1 |
| DB08437 | — | Puromycin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 2,775 |
| OHX | osmium (III) hexammine | 294 |
| CL | CHLORIDE ION | 267 |
| SPD | SPERMIDINE | 176 |
| Kmetal | POTASSIUM ION | 164 |
| NAmetal | SODIUM ION | 153 |
| SRmetal | STRONTIUM ION | 86 |
| CDmetal | CADMIUM ION | 65 |
| SPM | SPERMINE | 45 |
| PUT | 1,4-DIAMINOBUTANE | 43 |
| UNX | UNKNOWN ATOM OR ION | 38 |
| PAR | PAROMOMYCIN | 14 |
| MNmetal | MANGANESE (II) ION | 13 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 7 |
| 8UZ | TC007 | 2 |
| NMY | NEOMYCIN | 2 |
| 84D | Dibekacin | 1 |
| 84G | Arbekacin | 1 |
| GIR | GIRODAZOLE | 1 |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO-6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)-5-METHYL-4-(METHYLAMINO)-TETRAHYDRO-2H-PYRAN-3,5-DIOL | 1 |